Updated Jul 16, 2026 · Last SEC filing 2026-06-24
Nuvation Bio Inc. (NUVB) has filed 12 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-24. 4 Form 8-K material event filings were reported by NUVB in the last 90 days. 3 Form 144 notices of proposed sale were filed for NUVB stock. InsiderAlpha tracks every NUVB SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001811063 |
|---|
| Form 4 filings (90d) | 12 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 3 |
| Latest Form 4 filing | 2026-06-24 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Wentworth Kerry | CHIEF REGULATORY OFFICER | S — Open-market sale | 63.0K | $6.02 | $379K | SEC | |
| Sauvage Philippe | Chief Financial Officer | M — Option exercise | 47.7K | $2.17 | $103K | SEC | |
| Markel Stacy | CHIEF PEOPLE OFFICER | S — Open-market sale | 125.0K | $6.03 | $753K | SEC | |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | M — Option exercise | 63.0K | $2.93 | $185K | SEC | |
| Markel Stacy | CHIEF PEOPLE OFFICER | M — Option exercise | 34.6K | $1.74 | $60K | SEC | |
| Markel Stacy | CHIEF PEOPLE OFFICER | M — Option exercise | 90.4K | $1.87 | $169K | SEC | |
| Sauvage Philippe | Chief Financial Officer | S — Open-market sale | 47.7K | $6.01 | $286K | SEC | |
| Mashal Robert | Insider | P — Open-market purchase | 25.0K | $4.73 | $118K | SEC | |
| Liu Dongfang | CHIEF MEDICAL OFFICER | M — Option exercise | 50.0K | $1.94 | $97K | SEC | |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | M — Option exercise | 36.8K | $2.93 | $108K | SEC | |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | S — Open-market sale | 36.8K | $5.01 | $184K | SEC | |
| Liu Dongfang | CHIEF MEDICAL OFFICER | S — Open-market sale | 50.0K | $5.02 | $251K | SEC | |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | M — Option exercise [10b5-1] | 100.0K | $1.87 | $187K | SEC | |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | S — Open-market sale [10b5-1] | 200.0K | $4.52 | $904K | SEC | |
| Wentworth Kerry | CHIEF REGULATORY OFFICER | M — Option exercise [10b5-1] | 100.0K | $1.94 | $194K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Nuvation Bio Inc. (NUVB). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Wentworth Kerry | 6 | $856K |
| Markel Stacy | 5 | $982K |
| Sauvage Philippe | 3 | $390K |
| Liu Dongfang | 3 | $348K |
| Mashal Robert | 2 | $118K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in NUVB insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live NUVB dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.